Skip to main content

KYBELLA

Generic: Deoxycholic Acid

Verified·Oct 26, 2026
Manufacturer
AbbVie
NDC
61168-101
RxCUI
1649975
Route
SUBCUTANEOUS
ICD-10 indication
E65

Affordability Check

How much will you actually pay for KYBELLA?

In 30 seconds, see every legitimate way to afford KYBELLA — Medicare copay, manufacturer copay card, Patient Assistance Program, grants, or cash.

Check my options →

About KYBELLA

What is this medication?

Kybella is an injectable prescription medicine used to improve the appearance and profile of moderate to severe fat below the chin, a condition often referred to as a double chin. It is the first and only FDA-approved injectable treatment specifically designed to contour and improve the submental area. This medication is intended for use in adults who want to reduce fullness in the neck and jawline without undergoing invasive surgical procedures.

The active ingredient in Kybella is synthetic deoxycholic acid, which is a naturally occurring molecule in the body that helps break down and absorb dietary fat. When injected into the fat beneath the chin, it permanently destroys fat cells, preventing them from storing or accumulating fat in the future. Once the desired aesthetic goal is achieved through a series of treatment sessions, further treatment is generally not expected because the targeted cells can no longer store fat.

Copay & patient assistance

  • Patient Copay Amount: Not Publicly Available
  • Maximum Annual Benefit Limit: Not Publicly Available
  • Core Eligibility Restrictions: Qualifying patients; residents of the U.S. only
  • RxBIN, PCN, and Group numbers: Not Publicly Available

External links go directly to the manufacturer's portal. RxCopays does not receive compensation for referrals.

Compare pricing elsewhere

RxCopays doesn't sell drugs or take referral fees. Here are the transparent-pricing directories we recommend checking alongside your insurance formulary.

We deep-link because transparency helps patients. None of these partners pay RxCopays.

Prior authorization & coverage

PayerPAStep therapyCopay tier

—

Medicare Part D

———

Related drugs

How this page is sourced

  • Drug identity verified against openFDA NDC Directory.
  • Label text (when shown) originates from NLM DailyMed.
  • Copay and assistance URLs verified periodically; if you hit a broken link, tell us.